EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Blood Iodine as a Potential Marker of the Risk of Cancer in BRCA1 Carriers

Adam Kiljańczyk, Milena Matuszczak iD, Wojciech Marciniak iD, Róża Derkacz iD, Klaudia Stempa iD, Piotr Baszuk iD, Marta Bryśkiewicz, Cezary Cybulski, Tadeusz Dębniak iD, Jacek Gronwald iD, Tomasz Huzarski, Marcin R Lener und 18 weitere

Nutrients · 06.06.2024 · 16 (11) · 1788

DOI: 10.3390/nu16111788 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, online erschienen am 06.06.2024. Verfasst von Adam Kiljańczyk und 29 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, ul. Unii Lubelskiej 1, 71-252 Szczecin, …. Hauptthemen laut MEDLINE: Breast Neoplasms, Ovarian Neoplasms, Iodine, BRCA1 Protein. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Minister of Science and Higher Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer and ovarian cancer pose a significant risk for BRCA1 carriers, with limited risk-reduction strategies. While improved screening helps in the early detection of breast cancer, preventive measures remain elusive. Emerging evidence suggests a potential link between iodine levels and modulation of cancer risk, but comprehensive studies are scarce. We conducted a prospective study among 989 BRCA1 carriers to assess the association between blood iodine levels and breast and ovarian cancer risk. Using inductively coupled plasma mass spectrometry, we measured blood iodine levels and observed a negative association with breast cancer risk, with a significantly lower risk observed in quartile 4 (iodine > 38.0 µg/L) compared with quartile 1 (iodine < 30 µg/L) (HR = 0.49; 95%CI: 0.27–0.87; p = 0.01). Conversely, a suggestive increase in ovarian cancer risk was observed at higher iodine levels (HR = 1.91; 95%CI: 0.64–5.67; p = 0.25). No significant association was found between iodine levels and overall cancer risk. Our results suggest the potential of iodine to reduce breast cancer risk in BRCA1 carriers after prophylactic oophorectomy but require further validation and investigation of its effect on ovarian cancer risk and overall mortality. These findings highlight the need for personalized strategies to manage cancer risk in BRCA1 carriers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsOvarian NeoplasmsIodineBRCA1 ProteinHumansFemaleMiddle AgedAdultProspective StudiesRisk FactorsHeterozygoteBiomarkers, TumorAged

Stichwörter der Autor:innen

BRCA1breast cancercancermicroelementsnutrientsovarian cancer

Substanzen

IodineBRCA1 ProteinBRCA1 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, ul. Unii Lubelskiej 1, 71-252 Szczecin, Poland.
  • Read-Gene, Grzepnica, ul. Alabastrowa 8, 72-003 Dobra, Poland.
  • Department of Clinical Genetics and Pathology, University of Zielona Góra, ul. Zyty 28, 65-046 Zielona Góra, Poland.
  • Women's College Research Institute, Women's College Hospital, University of Toronto, Toronto, ON M5G 1N8, Canada.
  • Department of Surgery and Oncology, University of Zielona Góra, Zyty 28, 65-046 Zielona Góra, Poland.
  • OPEN, Kazimierza Wielkiego 24 St, 61-863 Poznań, Poland.

ORCID-Profile: Milena Matuszczak, Wojciech Marciniak, Róża Derkacz, Klaudia Stempa, Piotr Baszuk, Tadeusz Dębniak, Jacek Gronwald, Marek Szwiec, Małgorzata Stawicka-Niełacna, Andrzej Jasiewicz, Tomasz Kluz, Joanna Tomiczek-Szwiec, Rodney J Scott, Steven A Narod, Jan Lubiński

Förderung

  • Minister of Science and Higher Education

Zitieren

APA

Kiljańczyk, A., Matuszczak, M., Marciniak, W., Derkacz, R., Stempa, K., Baszuk, P., Bryśkiewicz, M., Cybulski, C., Dębniak, T., Gronwald, J., Huzarski, T., Lener, M. R., Jakubowska, A., Cheriyan, A., Szwiec, M., Stawicka-Niełacna, M., Godlewski, D., Prusaczyk, A., Jasiewicz, A., …, & Lubiński, J. (2024). Blood Iodine as a Potential Marker of the Risk of Cancer in BRCA1 Carriers. Nutrients, 16(11), 1788. https://doi.org/10.3390/nu16111788

Vancouver

Kiljańczyk A, Matuszczak M, Marciniak W, Derkacz R, Stempa K, Baszuk P, et al. Blood Iodine as a Potential Marker of the Risk of Cancer in BRCA1 Carriers. Nutrients. 2024;16(11):1788. doi:10.3390/nu16111788

BibTeX
@article{Kiljaczyk2024,
  author = {Kiljańczyk, Adam and Matuszczak, Milena and Marciniak, Wojciech and Derkacz, Róża and Stempa, Klaudia and Baszuk, Piotr and Bryśkiewicz, Marta and Cybulski, Cezary and Dębniak, Tadeusz and Gronwald, Jacek and Huzarski, Tomasz and Lener, Marcin R and Jakubowska, Anna and Cheriyan, Angela and Szwiec, Marek and Stawicka-Niełacna, Małgorzata and Godlewski, Dariusz and Prusaczyk, Artur and Jasiewicz, Andrzej and Kluz, Tomasz and Tomiczek-Szwiec, Joanna and Kilar-Kobierzycka, Ewa and Siołek, Monika and Wiśniowski, Rafał and Posmyk, Renata and Jarkiewicz-Tretyn, Joanna and Sun, Ping and Scott, Rodney J and Narod, Steven A and Lubiński, Jan},
  title = {Blood Iodine as a Potential Marker of the Risk of Cancer in BRCA1 Carriers},
  journal = {Nutrients},
  year = {2024},
  volume = {16},
  number = {11},
  pages = {1788},
  doi = {10.3390/nu16111788}
}
Kostenlos starten →